Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactolyze study (Boresha Afya)
PACTR202108480098476Phase 3Recruiting
- Sponsor
- National Institutes of Health
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes, Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of lactoferrin and lysozyme in diarrhea and Malnutrition (4 arms), sponsored by National Institutes of Health. Started Jan 2022; status: recruiting.
02
Drugs
lactoferrinlysozyme
03
Conditions
diarrheaMalnutrition
Beyond the preview
Go deeper on PACTR202108480098476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108480098476.